![Frank Mathias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Mathias
Amministratore Delegato presso
OXFORD BIOMEDICA PLC
Patrimonio netto: 157 840 $ in data 30/09/2026
Profilo
Dr. Frank Mathias is a Chairman at ArcticZymes Technologies ASA, a Chief Executive Officer & Director at Oxford Biomedica Plc, a Chairman at Vfa Bio, a Chairman-Supervisory Board at August Faller GmbH & Co. KG and a Chief Executive Officer at OXB US, Inc. He is on the Board of Directors at Oxford Biomedica Plc, Rentschler Biopharma SE, Seqens SAS, leon-nanodrugs GmbH, LEUKOCARE AG, Mediatum GmbH and Rentschler Biotechnologie Beteiligungs GmbH.
Dr. Mathias was previously employed as an Independent Member-Supervisory Board by MediGene AG, a Member-Executive Board by MediGene AG, a Chief Executive Officer by AMGEN GmbH, a Chief Executive Officer by Dr. Rentschler Holding GmbH & Co. KG, a Manager-International Product by Hoechst AG, and a General Manager by Servier Deutschland GmbH.
He also served on the board at Catherex, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0,02% | 31/12/2025 | 20.000 ( 0,02% ) | 138 690 $ | 30/09/2026 |
| 31/12/2025 | 9.000 ( 0,02% ) | 19 150 $ | 30/09/2026 |
Posizioni attive di Frank Mathias
| Società | Posizione | Inizio |
|---|---|---|
| OXFORD BIOMEDICA PLC | Amministratore Delegato | 27/03/2023 |
| ARCTICZYMES TECHNOLOGIES ASA | Presidente | 26/06/2024 |
August Faller GmbH & Co. KG
 August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Presidente | - |
Vfa Bio | Presidente | - |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Direttore/Membro del Consiglio | - |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Direttore/Membro del Consiglio | - |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Direttore/Membro del Consiglio | - |
Mediatum GmbH | Direttore/Membro del Consiglio | - |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Direttore/Membro del Consiglio | 31/03/2023 |
Precedenti posizioni note di Frank Mathias
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Frank Mathias
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in pharmaceutical research and production | Commercial Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seqens SAS
 Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics | Process Industries |
August Faller GmbH & Co. KG
August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Process Industries |
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Health Services |
Servier Deutschland GmbH
 Servier Deutschland GmbH Pharmaceuticals: MajorHealth Technology Engages in research, development and distribution of pharmaceutical products | Health Technology |
Catherex, Inc.
 Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Mediatum GmbH | |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
Rentschler Biotechnologie Beteiligungs GmbH
Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Finance |
Vfa Bio |
